LONSURF
Identification of Lonsurf
| No description |
Google image searchProduct monograph
Active ingredients
trifluridine, 15 MG
tipiracil (tipiracil hydrochloride), 6.14 MG
DIN: 02472104
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: TAIHO PHARMA CANADA, INC.
Date: 22-MAR-2018
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01B — ANTIMETABOLITES (ATC, ATC/DDD)
- L01BC — Pyrimidine analogues (ATC, ATC/DDD)
- L01BC59 — TRIFLURIDINE, COMBINATIONS (ATC/DDD)
Reference brand drug: Lonsurf
